Comparative effectiveness of prophylactic strategies for preeclampsia: a network meta-analysis of randomized controlled trials
Finding strategies for preventing preeclampsia is a top priority in the field of preeclampsia research. In this study, the authors reviewed all research papers available up until September 2021 that reported the effect of a preeclampsia prevention strategy and compared the strategies and how well they worked. (What is known as a meta-analysis.)
A total of 130 trials and 112,916 participants were included in this study, spanning 13 strategies for preeclampsia prevention. The strategies studied were lifestyle strategies (exercise, rest), medications (aspirin, metformin, pravastatin, low molecular weight heparin), and supplements (fish oil, folic acid, magnesium, selenium, vitamin C and E, vitamin D, and calcium). The analysis found that aspirin, exercise, calcium supplementation, vitamin D supplementation and low-molecular-weight heparin were all successful strategies for reducing risk for preeclampsia.
When comparing these successful strategies to one another, none were superior to the other for preeclampsia prevention. However, exercise was superior compared to aspirin and calcium supplementation, when considering reducing risk for all pregnancy-induced hypertension diagnoses.
Take Home Message: The sheer number of articles available to analyze in this study is promising evidence for progress in the field of preeclampsia prevention. This article shows there are several worthwhile strategies for patients to discuss with their health care provider to possibly implement to reduce their risk for preeclampsia. A lot more research is still needed to improve preeclampsia prevention.
Link: https://www.ajog.org/article/S0002-9378(22)00819-5/fulltext
Citation: Liu, Yuan-hui et al. Comparative effectiveness of prophylactic strategies for preeclampsia: a network meta-analysis of randomized controlled trials American Journal of Obstetrics & Gynecology, Volume 228, Issue 5, 535 - 546 (2023). https://doi.org/10.1016/j.ajog.2022.10.014
Your story is needed to improve outcomes for moms like you. Add your voice to critical preeclampsia research to ensure that every story is heard.
Frequently asked questions about the Preeclampsia Registry, a patient-driven registry and biobank.
The Preeclampsia Foundation offers research funding, study recruitment, and other patient engagement services to researchers.
We provide research grant funding to advance progress towards detection, prevention, or treatment of preeclampsia, HELLP syndrome, and other hypertensive disorders of pregnancy.
Preeclampsia is a serious hypertensive disorder of pregnancy that can put both mothers and babies at risk. Low-dose aspirin can help prevent it in some high-risk pregnancies, but identifying who shoul...
Preeclampsia is a pregnancy complication that can affect a woman's health even after her baby is born. Women who have had preeclampsia are more likely to develop high blood pressure and heart disease...
Preeclampsia is a serious high blood pressure condition that affects about 1 in 10 pregnancies worldwide and can lead to severe complications for moms and babies. It can also increase long-term health...
Researchers believe a standard approach to studying placental disorders of pregnancy will improve future studies, guidelines, and treatments. The Preeclampsia Foundation and Preeclampsia Foundation C...
The Preeclampsia Foundation today announced Hena Patel, MD, and Sarah E. Harkins, PhD, RN, as recipients of its 2027 Vision Grants. These highly competitive monetary awards of $20,000 each recognize p...
